Penicillin allergy evaluation in hospitalized patients with hematologic malignancy.
Vima M PatelBrian ChuKeith W HamiltonCassandra BellamyChristina HarkerJoshua S BryerBridget E ShieldsRebecca L HirshOlajumoke O FadugbaRobert G MichelettiPublished in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2023)
A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactams during follow-up. Providers found the PATS valuable.